UBS AM’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
+100,000
| New | +$248K | ﹤0.01% | 2543 |
|
|
2024
Q4 | – | Sell |
-18,600
| Closed | -$80.9K | – | 2663 |
|
|
2024
Q3 | $80.9K | Hold |
18,600
| – | – | ﹤0.01% | 2785 |
|
|
2024
Q2 | $86.7K | Buy |
+18,600
| New | +$86.7K | ﹤0.01% | 2775 |
|
|
2021
Q4 | – | Sell |
-24,100
| Closed | -$204K | – | 2847 |
|
|
2021
Q3 | $204K | Hold |
24,100
| – | – | ﹤0.01% | 2689 |
|
|
2021
Q2 | $294K | Buy |
24,100
+13,600
| +130% | +$166K | ﹤0.01% | 2649 |
|
|
2021
Q1 | $255K | Buy |
10,500
+3,000
| +40% | +$72.8K | ﹤0.01% | 2520 |
|
|
2020
Q4 | $240K | Buy |
+7,500
| New | +$240K | ﹤0.01% | 2464 |
|